Faropenem Sustained Release Tablets 300 Mg – Farohit 300 SR

Faropenem Sustained Release Tablets 300 mg — Farohit-300 SR

Composition: Faropenam Sodium 300 Sustained release

Faropenem Sustained Release Tablets 300 mg are employed in the management of a broad spectrum of bacterial infections arising from both Gram-positive and Gram-negative organisms. This formulation is particularly indicated for respiratory tract infections, urinary tract disorders, skin and soft tissue infections, and otolaryngological ailments. Its sustained-release mechanism ensures prolonged plasma concentration, thereby enhancing therapeutic efficacy while minimizing dosing frequency. The medication’s robust antibacterial profile renders it a preferred agent in resistant or recurrent microbial pathologies.

Essential Highlights of Farohit-300 SR — (Faropenem Sustained Release Tablets 300 mg)

➣Active Ingredient: Faropenem Sodium 300 mg

➣Dual Mechanism: Inhibits bacterial cell wall synthesis and resists beta-lactamase degradation

➣Better Tolerability: Gentle on the gastrointestinal tract with minimal adverse effects

➣Mode of Action: Bactericidal activity by disrupting bacterial cell wall integrity, leading to bacterial death

Can be prescribed by—

➣Physicians/General Practitioners
➣Infectious Disease Specialists
➣Pediatricians
➣Pulmonologists & ENT Specialists

Disclaimer: To be administered only under the supervision of a qualified healthcare professional. Intended for use by registered medical practitioners. Not for public promotion.